Skip to content
Sign in — free

GNLN: figures a later filing reports differently

A number taken from the original GNLN filing, or a report built on it, can differ from what the latest filing reports for the same period. Both filings are named below.

CompanyLine itemYearAs first filedLatest filingLatest vs first filed
GNLNCheck itNet income2022
ends 2022-12-31
-$115,760,000
filed 2023-03-31 · 0001743745-23-000014
-$169,509,000
filed 2024-07-19 · 0001493152-24-028387
-46.4%
GNLNCheck itOperating income2022
ends 2022-12-31
-$127,734,000
filed 2023-03-31 · 0001743745-23-000014
-$184,102,000
filed 2024-07-19 · 0001493152-24-028387
-44.1%
GNLNCheck itTotal assets2022
ends 2022-12-31
$146,053,000
filed 2023-03-31 · 0001743745-23-000014
$89,685,000
filed 2024-07-19 · 0001493152-24-028387
-38.6%

Filings that revised earlier statements

  • 2026-08-14 10-Q: earlier figures differ from what the filing before reported (per-share and share figures moved in inverse proportion). later filings revise 5 figures for periods ending 2025-06-30; largest change 700.6%.
  • 2026-05-15 10-Q: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 7 figures for periods ending 2025-03-31, 2025-12-31; largest change 693.8%.
  • 2026-03-31 10-K: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 1 figure for periods ending 2024-12-31; largest change 16.3%.
  • 2025-11-14 10-Q: earlier figures differ from what the filing before reported (per-share and share figures moved in inverse proportion). later filings revise 4 figures for periods ending 2024-09-30; largest change 240455.7%.
  • 2025-08-14 10-Q: earlier figures differ from what the filing before reported (per-share and share figures moved in inverse proportion). later filings revise 5 figures for periods ending 2024-06-30, 2024-12-31; largest change 74900.0%.
  • 2025-05-15 10-Q: earlier figures differ from what the filing before reported (per-share and share figures moved in inverse proportion). later filings revise 4 figures for periods ending 2024-03-31; largest change 6645.4%.
  • 2025-03-21 10-K: earlier figures differ from what the filing before reported (per-share and share figures moved in inverse proportion). later filings revise 3 figures for periods ending 2023-12-31; largest change 90.9%.
  • 2024-01-08 10-Q/A: an amendment whose figures differ from the filing it amends. later filings revise 16 figures for periods ending 2022-12-31, 2023-06-30; largest change 75.9%.
  • 2024-01-08 10-Q/A: an amendment whose figures differ from the filing it amends. later filings revise 13 figures for periods ending 2023-03-31; largest change 75.3%.
  • 2024-01-05 10-K/A: an amendment whose figures differ from the filing it amends. later filings revise 30 figures for periods ending 2022-09-30, 2022-12-31; largest change 1700.0%.
  • 2023-11-15 8-K Item 4.02: the company withdrew reliance on earlier financial statements. later filings revise 77 figures for periods ending 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30; largest change 1700.0%.
  • 2023-08-14 10-Q: earlier figures differ from what the filing before reported (the filing reports a share split). later filings revise 6 figures for periods ending 2022-06-30, 2022-12-31; largest change 900.0%.
  • 2023-05-15 10-Q: earlier figures differ from what the filing before reported (the filing reports a share split). later filings revise 4 figures for periods ending 2022-03-31; largest change 1900.0%.
  • 2023-03-31 10-K: earlier figures differ from what the filing before reported (the filing reports a share split). later filings revise 9 figures for periods ending 2021-12-31; largest change 1906.3%.
  • 2022-11-14 10-Q: earlier figures differ from what the filing before reported (the filing reports a share split). later filings revise 8 figures for periods ending 2021-09-30; largest change 1897.6%.
  • 2022-08-15 10-Q: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 9 figures for periods ending 2021-06-30, 2021-12-31; largest change 1918.8%.
  • 2022-05-16 10-Q: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 5 figures for periods ending 2021-03-31, 2021-12-31; largest change 17.0%.
  • 2021-05-17 10-Q: earlier figures differ from what the filing before reported (the filing reports discontinued operations). later filings revise 3 figures for periods ending 2020-03-31, 2020-12-31; largest change 55.2%.
  • 2021-03-31 10-K: earlier figures differ from what the filing before reported (the filing reports discontinued operations). later filings revise 3 figures for periods ending 2019-12-31; largest change 27.7%.
  • 2020-11-16 10-Q: earlier figures differ from what the filing before reported (the filing reports discontinued operations). later filings revise 1 figure for periods ending 2019-09-30; largest change 30.3%.
  • 2020-08-11 10-Q: earlier figures differ from what the filing before reported (cause not determined: net income, equity or total assets changed and the filing reports no split, discontinued operations or accounting-principle change). later filings revise 3 figures for periods ending 2019-06-30, 2020-03-31; largest change 45.1%.
  • 2020-06-09 10-Q: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 21 figures for periods ending 2019-03-31, 2019-12-31; largest change 1392.7%.
  • 2019-08-13 10-Q: earlier figures differ from what the filing before reported (reclassification: net income, equity and total assets unchanged). later filings revise 17 figures for periods ending 2017-12-31, 2018-12-31, 2019-03-31; largest change 93.3%.

All recast figures · Check a figure

Checking the figures in a client letter or report? See the one-document pilot.

Not investment advice.